The Use of OCT as a Biomarker in Neuro-ophthalmology (Ongoing)

Posted On 2019-06-13 16:23:25

This focused issue on “The use of OCT as a biomarker in neuro-ophthalmology” is edited by Dr. Fiona Costello, from Departments of Surgery, Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada, and Steffen Hamann, from Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Dr. Fiona Costello’s area of research focuses on using the eye as a model for brain disorders including multiple sclerosis and tumors. She has published nearly 100 peer reviewed papers, 17 book chapters and has been invited to give over 160 national and international presentations at numerous academic venues. Together with her colleagues, she has received more than eight million dollars in research funding.

Dr. Steffen Hamann is a neuro-ophthalmologist focusing on providing diagnosis and management of neurologically based eye conditions such as vision loss, pupillary disturbances and double vision. He’s dedicated to advancing the field through ongoing clinical research, especially in optic neuropathies including optic disc drusen and conditions with increased intracranial pressure and edema of the optic nerve head.

Focused issue outline:

  1. Introduction/Preface to this focused issue
    Fiona Costello, Departments of Clinical Neurosciences & Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
    Steffen Hamann, Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  2. Overview of OCT
    Peter Maloca, Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland
  3. OCT in Inflammatory Optic Neuropathies
    Alex Brandt, Neurodiagnostics Laboratory, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Germany
  4. OCT in Optic Disc Drusen
    Lulu Bursztyn and Alex Fraser, Department of Ophthalmology, Western University, London, Ontario, Canada
  5. OCT in Compressive Lesions of the Anterior Visual Pathway
    Clare Fraser, Save Sight Institute, Faculty of Health and Medicine, The University of Sydney, Sydney, Australia
  6. OCT in high intracranial pressure states
    Heather Moss, Departments of Ophthalmology and Neurology & Neurological Sciences (HEM), Stanford University, Palo Alto, California, USA
  7. OCT in Ischemic Optic Neuropathy
    Prem Subramaniam, Department of Ophthalmology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA
  8. OCT in Toxic, Metabolic, and Inherited Optic Neuropathies
    Gregory Van Stavern, Department of Ophthalmology and Visual Neurosciences, Washington University School of Medicine, St Louis, MO, USA
  9. OCT in Neurodegenerative Disorders
    Hong Jiang & Jay Wang, Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA
  10. OCT in Pediatric Neuro-Ophthalmology
    Ann Yeh, Neurology, The Hospital for Sick Children, Toronto, Canada